Solventum Corporation (SOLV) Stock Forecast

NYSE: SOLVAnalyst ratings, price target and estimates.

SOLV analyst forecast

as of October 18, 2026
Analyst consensus
Buy
3.80 / 5 from 15 analysts
Price target
$94.69
average of analyst targets
Upside to target
+10.4%
from the latest close
Next earnings
November 5, 2026
EPS estimate $1.35
52-week range
$62.49 – $92.44

SOLV analyst ratings

15 analysts
Strong buy
747%
Buy
17%
Hold
533%
Sell
17%
Strong sell
17%

Number of analysts at each rating.

SOLV price target

Price $85.81Target $94.69
52-week low $62.4952-week high $92.44

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

SOLV earnings per share estimates

Solventum Corporation EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)$1.35$1.29$1.43$1.50−9.8%11
Current fiscal year (2026)$7.14$6.55$7.55$6.11+16.9%15
Next fiscal year (2027)$7.25$6.46$7.60$7.14+1.5%15

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

SOLV revenue estimates

Solventum Corporation revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$1.94B$1.91B$1.97B−7.7%11
Current fiscal year (2026)$8.23B$8.10B$8.26B−1.2%13
Next fiscal year (2027)$8.52B$8.38B$8.61B+3.6%13

SOLV EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

SOLV revenue: reported and forecast

Reported revenueEstimate (average; low–high)

SOLV EPS estimate revisions

Solventum Corporation EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)$1.42$1.35$1.35$1.35$1.35−4.7%2 up · 0 down
Current fiscal year (2026)$6.55$7.18$7.14$7.14$7.14+9.1%2 up · 0 down
Next fiscal year (2027)$7.05$7.22$7.23$7.23$7.25+2.8%3 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

SOLV earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 11 quarters; SOLV beat in 10 of 11.

What analysts expect from SOLV

15 analysts cover Solventum; their consensus rating is buy (3.80 on a 1–5 scale, where 5 is a strong buy). The average price target is $94.69, 10.4% above the latest close of $85.81. Analysts expect earnings of $7.14 per share for 2026, +16.9% from a year earlier. For 2027 the average estimate is $7.25 per share on revenue of $8.5 billion. Solventum beat the EPS estimate in 10 of the last 11 quarters.

Related: SOLV income statement, SOLV key metrics, SOLV chart. See the SOLV stock overview for the latest quote and news.

SOLV forecast FAQ

What is Solventum's price target?

The average analyst price target for Solventum is $94.69, 10.4% above the latest close of $85.81.

Is Solventum a buy, hold or sell?

Of 15 analysts covering Solventum, 7 rate it a strong buy, 1 a buy, 5 a hold, 1 a sell and 1 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.

What is Solventum's EPS forecast?

Analysts forecast $7.14 per share for 2026 (range $6.55 to $7.55); for 2027 the estimate is $7.25.

What is Solventum's revenue forecast?

The average revenue estimate for 2026 is $8.2 billion, growth of −1.2%; for 2027 it is $8.5 billion.

When does Solventum report earnings?

Solventum is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $1.35.

Does Solventum usually beat earnings estimates?

Solventum reported EPS at or above the analyst estimate in 10 of the last 11 quarters.

Medical Instruments & Supplies: forecast